Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Erschienen in: memo - Magazine of European Medical Oncology 2/2019

01.06.2019 | editorial

Overcoming resistance and bypassing checkpoints—possible new therapeutic frontiers in oncology

verfasst von: MD PhD Andreas Pircher

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten
share
TEILEN

Excerpt

The armamentarium of systemic oncological therapies has constantly increased in recent years and in addition to standard chemotherapy now includes targeted therapies, anti-hormonal therapies, anti-angiogenic therapies and immunotherapy. All these therapeutic approaches have been proven a clinical success, often significantly prolonging the lives of cancer patients. However, mostly tumours progress as resistance to these therapies develops biologically, defined by either primary or secondary resistance mechanisms. …
Literatur
Metadaten
Titel
Overcoming resistance and bypassing checkpoints—possible new therapeutic frontiers in oncology
verfasst von
MD PhD Andreas Pircher
Publikationsdatum
01.06.2019
Verlag
Springer Vienna
Erschienen in
memo - Magazine of European Medical Oncology / Ausgabe 2/2019
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-019-0495-4

Weitere Artikel der Ausgabe 2/2019

memo - Magazine of European Medical Oncology 2/2019 Zur Ausgabe